Immunicum is listed on NASDAQ OMX First North Premier under the ticker IMMU.
A unique approach to apply allogeneic dendritic cells in immuno-oncology.Read more
- 24 May 2017
- 31 Mar 2017
- 4 Jan 2017
Developing innovative cancer immunotherapies
We are on a journey towards the world’s first patient unique, off-the-shelf cancer treatment. Get to know the technology that will take us there.Learn more